COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,668 Articles (22,913 medRxiv, 8,755 bioRxiv)

Most recent first Previous |  Page 1337: Articles 13361-13370  | Next

Proactive COVID-19 testing in a partially vaccinated population
McGee, R. S., Homburger, J. R., Williams, H. E., Bergstrom, C. T., Zhou, A. Y.
10.1101/2021.08.15.21262095 — Posted: 2021-08-18
Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities
McLean, H. Q., Grijalva, C. G., Hanson, K. E., Zhu, Y., Deyoe, J. E., Meece, J. K., Halasa, N. B., Chappell, J. D., Mellis, A., Reed, C., Belongia, E. A., Talbot, H. K., Rolfes, M. A.
10.1101/2021.08.16.21262121 — Posted: 2021-08-18
Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospital
Horspool, A. M., Russ, B. P., Wolf, M. A., Kang, J., Blackwood, C. B., Hall, J. M., Wong, T. Y., DeJong, M. A., Bitzer, G., Bevere, J. R., Eggleston, R., Stewart, A., Costello, L., Welch, S., Kieffer, T., Hodder, S., Damron, F. H.
10.1101/2021.08.16.21262128 — Posted: 2021-08-18
Point of emission air filtration enhances protection of health care workers against skin contamination with virus aerosol
Landry, S. A., Subedi, D., MacDonald, M. I., Dix, S., Kutey, D., Barr, J., Mansfield, D., Hamilton, G., Edwards, B., Joosten, S.
10.1101/2021.08.15.21261997 — Posted: 2021-08-18
A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity?
Sughayer, M. A., Mansour, A., Al Nuirat, A., Souan, L., Abdel-Razeq, R., Siag, M.
10.1101/2021.08.15.21261584 — Posted: 2021-08-18
Dynamics of seroconversion of anti-SARS-CoV-2 IgG antibodies in the Czech unvaccinated population: nationwide prospective seroconversion (PROSECO) study
Piler, P., Thon, V., Andryskova, L., Dolezel, K., Kostka, D., Pavlik, T., Dusek, L., Pikhart, H., Bobak, M., Klanova, J.
10.1101/2021.08.15.21262007 — Posted: 2021-08-18
COVID-19 infection, hospitalisation and death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project.
Rutter, M., Lanyon, P. C., Grainge, M. J., Hubbard, R., Peach, E., Bythell, M., Stilwell, P., Ashton, J., Stevens, S., Pearce, F. A.
10.1101/2021.08.17.21260846 — Posted: 2021-08-18
Non-pharmaceutical interventions, vaccination and the Delta variant: epidemiological insights from modelling England's COVID-19 roadmap out of lockdown
Sonabend, R., Whittles, L. K., Imai, N., Perez-Guzman, P. N., Knock, E. S., Rawson, T., Gaythorpe, K. A., Djaafara, B. A., Hinsley, W., FitzJohn, R. G., Lees, J. A., Thekke Kanapram, D., Volz, E. M., Ghani, A. C., Ferguson, N. M., Baguelin, M., Cori, A.
10.1101/2021.08.17.21262164 — Posted: 2021-08-18
SARS-CoV-2 alpha variant: is it really more deadly? A population-level observational study.
Moore, C. M., Sergienko, R., Arbel, R.
10.1101/2021.08.17.21262167 — Posted: 2021-08-18
Effectiveness of COVID-19 Vaccines among Incarcerated People in California State Prisons: A Retrospective Cohort Study
Chin, E. T., Leidner, D. T., Zhang, Y., Long, E., Prince, L., Schrag, S. J., Verani, J. R., Wiegand, R. E., Alarid-Escudero, F., Goldhaber-Fiebert, J. D., Studdert, D. M., Andrews, J. R., Salomon, J. A.
10.1101/2021.08.16.21262149 — Posted: 2021-08-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).